Poxel pivots to different programs, but questions abound over imeglimin
Poxel pivots to different programs, but questions abound over imeglimin [...]
Novo Nordisk puts $1.2B on the table for Prothena’s ATTR drug, teeing up Alnylam challenge and cardiovascular expansion
Novo Nordisk puts $1.2B on the table for Prothena’s ATTR [...]
FDA puts Sigilon’s hemophilia cell therapy trial on hold thanks to safety concerns
FDA puts Sigilon’s hemophilia cell therapy trial on hold thanks [...]
J&J, Vor ally to assess bispecific and stem cell therapy in AML
J&J, Vor ally to assess bispecific and stem cell therapy [...]
U.K. regulator accepts Humanigen’s COVID drug for speedy review, as analysts spell out reasons to be hopeful for FDA nod
U.K. regulator accepts Humanigen’s COVID drug for speedy review, as [...]
Britain bets on biotech as billions set to boost life sciences sector
Britain bets on biotech as billions set to boost life [...]
Muna raises $73M to go after Alzheimer’s, Parkinson’s and MS
Muna raises $73M to go after Alzheimer’s, Parkinson’s and MS [...]
Large differences in phase 3 overall survival spark FDA hold on Oncopeptides’ multiple myeloma drug
Large differences in phase 3 overall survival spark FDA hold [...]
Elevation raises $65M to turn serial failure into tumor-agnostic success
Elevation raises $65M to turn serial failure into tumor-agnostic success [...]
Pfizer passes COVID-19 vaccine safety milestone, reveals 95% efficacy ahead of EUA
Pfizer passes COVID-19 vaccine safety milestone, reveals 95% efficacy ahead [...]